Learn how PTC Therapeutics developed our spinal muscular atrophy (SMA) therapy from our founder and CEO Stuart Peltz, VP & Head of Group External Affairs and Alliance Management Nikolai Naryshkin, and other members of our dedicated team.
SMA Therapy: A Winding Path to Success
Read Next
Martin Stengård: Making Esports Champions with DuchenneCan mindset
Martin Stengård has many strings to his bow. Following his pursuit of music as a student and retraining in...
Lila Plakolli: Empowering others to embrace who they are
Lila is a disability activist and performer living with Duchenne. Through their dynamic theatre performances and powerful advocacy speeches...
2022: A Year of Many Firsts
For PTC, 2022 was a milestone-reaching, patient-supporting, award-winning, employee-engaging, community-driven year. It was also another year of many firsts....